Jul 30, 2026 08:02AM
Jul 10, 2026 08:02AM
Jul 10, 2026 08:00AM
Jul 6, 2026 09:00AM
Jun 25, 2026 08:15AM
Jun 25, 2026 08:15AM
Jun 17, 2026 08:00AM MIRA Pharmaceuticals files Phase 2a trial protocol for CIPN drug
Jun 17, 2026 08:00AM
Jun 4, 2026 08:02AM
Jun 4, 2026 08:00AM
May 27, 2026 08:00AM
May 27, 2026 08:00AM
May 14, 2026 08:01AM
May 14, 2026 08:00AM MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
May 13, 2026 08:04AM
May 13, 2026 08:00AM
Mar 23, 2026 09:03AM
Mar 23, 2026 09:00AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM MIRA Pharmaceuticals starts final cohort of Ketamir-2 phase 1 trial
Feb 3, 2026 07:30AM
Oct 24, 2025 07:30AM
Oct 24, 2025 07:30AM
Oct 16, 2025 04:05PM
Oct 16, 2025 07:30AM
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM MIRA Pharmaceuticals completes SKNY acquisition, adds $5M in securities
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM
Sep 22, 2025 08:00AM
Sep 16, 2025 07:30AM
Sep 16, 2025 07:30AM
Sep 15, 2025 04:06PM
Sep 12, 2025 07:30AM MIRA Pharmaceuticals shareholders approve SKNY acquisition
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 12, 2025 08:32AM
Aug 12, 2025 08:30AM
Jul 30, 2025 07:30AM
Jul 30, 2025 07:30AM MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM
Jul 3, 2025 08:02AM
Jul 3, 2025 08:00AM
Jun 30, 2025 08:00AM MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive Agreement for Acquisitio
Jun 25, 2025 08:00AM

426,816 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All